Abstract
As presented in other chapters of this book, there is a plethora of contraceptive methods currently in use to prevent an unwanted pregnancy. Many of these methods are safe and highly effective for blocking fertility while others are less effective or have health risks associated with their use. All current contraceptive methods have some shortcomings related either to efficacy, safety, cost, ease of use, or conflict with moral or religious values. In many circumstances, poor families or those living in developing countries have no means to access methods for planning family size or if methods are available, they are not affordable. Thus, it is apparent to those knowledgeable of family planning needs that additional contraceptive technology is essential to meet current and future demands.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Stevens VC, Powell JE, Rickey M, et al. Studies of various delivery systems for a human chorionic gonadotropin vaccine. In Alexander NJ, Griffin PD, Spieler JM, Waites GMH (eds): Gamete Interaction. New York, Wiley-Liss, 1990; 549–563.
Ladd A, Tsong YY, Prabhu G, et al. Effects of long-term immunization against LHRH and androgen treatment on gonadal function. J Reprod Immunol 1989; 15: 85–101.
Joel CA. Historical survey of research on spermatozoa from antiquity to the present. In Joel CA (ed): Fertility Disturbances in Men and Women. Basel, Krager, 1971; 3–20.
Goldberg E, Shelton JA. Immunosuppression of fertility by LDH-C4. In Talwar GP (ed): Immunological Approaches to Contraception and Promotion of Fertility. New York, Plenum Press, 1986; 219–230.
Mahi-Brown CA, Vandevoort CA, Ryan P, et al. Immunization of male but not female mice with the sperm-specific isozyme of lactate de-hydrogenase (LDH-C4) impairs fertilization in vivo. Am J Reprod Immunol 1990; 24: 1–8.
Goldberg E. LDH-C4 as an immunocontraceptive model. In Alexander NJ, Griffin PD, Spieler JM, Waites GMH (eds): Gamete Interaction. New York, Wiley-Liss, 1990; 63–74.
Herr JC, Flickinger CJ, Humyk M, et al. Biochemical and morphological characterization of the intra-acrosomal antigen SP-10 from human sperm. Biol Reprod 1990; 42: 181–193.
Primakoff P, Lathrop W, Woolman L. Fully effective contraception in male and female guinea pigs immunized with the sperm protein PH-20. Nature 1988; 335: 543–546.
Sacco Ag, Yarewicz EC, Subramanian MG. Effect of varying dosages and adjuvants on antibody response in squirrel monkeys immunized with porcine zona pellucida glycoprotein ZP-3. Am J Reprod Immunol 1989; 21: 1–8.
Millar SE, Chamow SM, Balir AW, et al. Vaccination with a synthetic zona pellucida peptide produces long-term contraception in female mice. Science 1989; 246: 935–938.
Stevens VC. Immunization of female baboons with haptencoupled gonadotropins. Obstet Gynecol 1973; 42: 496–506.
Talwar GP, Sharma NC, Dubey SK, et al. Isoimmunization against human chorionic gonadotropin with conjugates of processed B- subunit of the hormone and tetanus toxoid. Proc Natl Acad Sei 1976; 73: 218–222.
Stevens VC, Cinader B, Powell JE, et al. Preparation and formulation of a hCG antifertility vaccine: selection of peptide immunogen. Am J Reprod Immunol 1981a; 6: 307–314.
Stevens VC, Cinader B, Powell JE, et al. Preparation and formulation of a hCG antifertility vaccine: selection of adjuvant and vehicle. Am J Reprod Immunol 1981b; 6: 315–321.
Lee AC, Powell JE, Tregear G, et al. A method for preparing B-hCG COOH peptide-carrier conjugates of predictable composition. Mol Immunol 1980; 17: 749–755.
Thau RB, Sundaram K. The mechanism of action of an antifertility vaccine in the rhesus monkey: reversal of the effects of antisera to the B-subunit of ovine luteinizing hormone by medroxy progesterone acetate. Fertil Steril 1980; 33: 317–321.
Nash H, Talwar GP, Segal S, et al. Observations on the antigenicity and clinical effects of a candidate antipregnancy vaccine: B-subunit of human chorionic gonadotropin linked to tetanus toxoid. Fertil Steril 1980; 34: 328–334.
Talwar GP, Guar A. Recent developments in immunocontraception. Am J Obstet Gynecol 1987; 157: 1075–1079.
Jones WR, Bradley J, Judd ST, et al. Phase I clinical trial of a World Health Organization birth control vaccine. Lancet 1988; 1: 1295–1298.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag New York, Inc.
About this chapter
Cite this chapter
Stevens, V.C. (1993). Immunological Contraception. In: Shoupe, D., Haseltine, F.P. (eds) Contraception. Clinical Perspectives in Obstetrics and Gynecology. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2730-4_19
Download citation
DOI: https://doi.org/10.1007/978-1-4612-2730-4_19
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-7645-6
Online ISBN: 978-1-4612-2730-4
eBook Packages: Springer Book Archive